XML 40 R23.htm IDEA: XBRL DOCUMENT v3.25.0.1
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION:
 12 Months Ended
Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION:

NOTE 12 - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION:

 

Balance sheets:

 

Inventory:

  

         
   December 31, 
   2024   2023 
   ($ in thousands) 
Finished goods  $18   $210 
Work in process   638    562 
Raw materials and supplies   1,914    1,334 
Total inventory  $2,570   $2,106 

 

 

INSPIREMD, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (continued)

 

NOTE 12 - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (continued):

 

  a. Accounts payable and accruals-other:

 

         
   December 31, 
   2024   2023 
   ($ in thousands) 
Employees and employee institutions  $3,414   $2,188 
Accrued vacation and recreation pay   369    287 
Accrued expenses   1,325    1,115 
Clinical trial accrual   519    744 
Current Operating lease liabilities   542    557 
Other   255    190 
Accounts Payable and Accruals - Other  $6,424   $5,081